Blood Group Typing Market Share Analysis, Growth Forecast

By -
Blood group typing is a procedure of determining what specific type of blood a person has, which depends on the presence of antigens on the red blood cells. It is done in organ donation process, to safely donate or receive a blood transfusion and to determine whether Rh factor is present on the surface of the red blood cell. Blood group typing is very important during pregnancy as it can prevent severe anaemia in the new born. There are various techniques and methods to detect the blood group. The global blood group typingmarket has witnessed significant growth due to the advancement in technology which has improved detection methods.
Blood group typing can be done via various tests namely, antigen typing, cross-matching tests, antibody screening, human leukocyte antigen (HLA) typing and ABO blood tests. Among the different blood group typing tests, antibody screening is expected to witness the fastest growth in the global market during the forecast period. Rising demand for early disease diagnosis and increase in chronic disorder cases is causing the growth in the usage of the antibody screening test for blood group typing.

Request for a sample: https://www.psmarketresearch.com/market-analysis/blood-group-typing-market/report-sample



Globally, the demand for blood group typing products and services was largest in hospitals due to the increasing awareness regarding the importance of blood donations and growth in the requirements of blood for surgical treatments. Other key end users in the global blood group typing market are clinical laboratories and blood banks.
The global blood group typing market is expected to grow significantly during the forecast period. The major driving force behind this growth are the increase in the use of blood group typing in forensic science; need for grouping of the blood during pregnancy and prenatal testing; growth in the number of road accidents and trauma cases that requires blood transfusion; increase in the demand of blood and blood products; and rise in blood donation. Blood group typing is very crucial for the detection of hemolytic disease of the newborn (HDN) in pregnant women which eventually stimulates the usage of blood group typing, hence causing the growth of the global market.

Make enquiry before buying the report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=blood-group-typing-market
They key players in the global blood group typing market are Bio-Rad Laboratories, Inc., Immucor, Inc., Quotient Limited, BAG Health Care GmbH, DAY medical SA, Grifols S.A., Ortho Clinical Diagnostics, Inc., Novacyt Group, DIAGAST, AXO Science, and Agena Bioscience, Inc.
In October 2016, Bio-Rad Laboratories, Inc., a manufacturer of life sciences and clinical diagnostic products, received the U.S. Food and Drug Administration (FDA) approval for its IH-1000 blood instrument.
In May 2014, Immucor’s PreciseType HEA Test received FDA approval to be used for screening blood donors for sickle cell trait (SCT). The PreciseType HEA test is the FDA-approved molecular assay designed to provide blood banks and clinicians with the detailed genetic matching information that they need to reduce the risk of alloimmunization and serious haemolytic reactions, which is especially problematic for patients receiving frequent blood transfusions.
Contact:
Mr. Kundan Kumar
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +18887787886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Connect with us: LinkedIn | Twitter | Google + | Facebook

Comments

Post a Comment

Popular posts from this blog

How is Increasing Focus on Personalized Medicine Driving Cancer/Tumor Profiling Market?

By -
Image
Every year, over 9.5 million people die as result of cancer, as per the World Health Organization (WHO), thereby becoming one of the major reasons for human mortality around the world. The disease, which is most prominently characterized by the presence of tumors, forms when a mutation (undesirable change) in a gene or protein causes a particular type of cell to divide faster than the rate of the normal cell death, thereby resulting in the growth of a visible mass.  Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/cancer-profiling-market/report-sample This is concurrent with the fact that among the genomics, proteomics, metabolomics, and epigenetics techniques, genomics is the most widely used one. As the root cause of the cancer can be determined by studying which gene mutated and how, targeted therapies can be devised. Such analysis can also help ascertain if the patient would be at risk of a relapse. All these techniques and technologies find ...
Read more

What are Major Factors Driving Progress of Global Next-Generation Antibody Therapeutics Market?

By -
Image
 The increasing number of technological developments in the healthcare industry is one of the major factors fuelling the surge in the demand for next-generation antibody therapeutics solutions throughout the globe. For instance, there have been major developments in the healthcare technologies over the last few years such as the development of bispecific antibodies (BsAbs), ADC technologies, and glycoengineered antibody. These advancements have significantly increased the application area of the antibody therapeutics. The other major factor propelling the demand for next-generation antibody therapeutics solutions is the increasing prevalence of chronic diseases across the world. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market/report-sample ADCs are widely considered to be much safer and effective than the conventionally used antibodies for cancer treatment as these are made by combining a biologically active cytot...
Read more

How is Popularity of Personalize Medicine Helping Oligonucleotide Synthesis Market Advance?

By -
Image
Though there are a set number of health conditions that can affect people, the actual effect they have can vary from one individual to another. This is because, though similar, every human is slightly different on the genetic level. Consequently, one treatment that works for one patient has no guarantee of working for another. With the realization of this fact, the medical specialty of personalized medicine has emerged, wherein the genetics of a person are studied to devise a suitable treatment. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/oligonucleotide-synthesis-market/report-sample With extensive research and development (R&D), scientists have realized that a lot of diseases are caused by mutations in a particular gene, and if that particular gene is somehow deactivated, the disease could be managed. One of the ways it is being done is by artificially producing an antisense oligonucleotide, which is a single-strand deoxyribonucleic a...
Read more